Antiproliferative and anticytotoxic effects of cell fractions and exopolysaccharides from Lactobacillus casei 01

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 721, Issue 2, 2011, Pages 157-162

  Liu, Chu Ting ^a   Chu, Fang Jung ^a   Chou, Cheng Chun ^a   Yu, Roch Chui ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

4 Nitroquinoline 1 oxide; Anticytotoxicity; Comet assay; Exopolysaccharides; Lactobacillus casei 01

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ANTIMUTAGENIC AGENT; CYTOTOXIC AGENT; EXOPOLYSACCHARIDE; PROBIOTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL FRACTIONATION; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN HT29; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPAIR; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LACTOBACILLUS CASEI; MUTAGENICITY; PRIORITY JOURNAL;

4-NITROQUINOLINE-1-OXIDE; ANTIMUTAGENIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; HT29 CELLS; HUMANS; INTESTINES; LACTOBACILLUS CASEI; MUTAGENS; POLYSACCHARIDES, BACTERIAL;

LACTOBACILLUS CASEI;

EID: 79952817294     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.01.005     Document Type: Article

References (25)

1. Hirayama K., Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000, 2:681-686.
2. Saikali J., Picard C., Freitas M., Holt P.R. Fermented milks, probiotic cultures, and colon cancer. Nutr. Cancer 2004, 49:14-24.
3. Choi S.S., Kim Y., Han K.S., You S., Oh S., Kim S.H. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett. Appl. Microbiol. 2006, 42:452-458.
4. Ewaschuk J.B., Walker J.W., Diaz H., Madsen K.L. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J. Nutr. 2006, 136:1483-1487.
5. Commane D., Hughes R., Shortt C., Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat. Res. 2005, 591:276-289.
6. Wong Y.N., Chang W.C., Clapper M., Engstrom P.F. Chemoprevention of colorectal cancer. Colorectal Cancer: Evidence-Based Chemotherapy Strategies 2006, 33-49. Humana Press Inc., Totowa, NJ. L.B. Saltz (Ed.).
7. Wollowski I., Rechkemmer G., Pool-Zobel B.L. Protective role of probiotics and prebiotics in colon cancer. Am. J. Clin. Nutr. 2001, 73:451S-455S.
8. Burns A.J., Rowland I.R. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 2004, 551:233-243.
9. Caldini G., Trotta F., Villarini M., Moretti M., Pawquini R., Scassellati-Sforzolini G., Cenci G. Screening of potential lactobacilli antigenotoxicity by microbial and mammalian cell-based tests. Int. J. Food Microbiol. 2005, 102:37-47.
10. Ou C.C., Ko J.L., Lin M.Y. Antioxidative effects of intracellular extracts of yogurt bacteria on lipid peroxidation and intestine 407 cells. J. Food Drug Anal. 2006, 14:304-310.
11. Yen G.C., Chiang H.C., Wu C.H., Yeh C.T. The protective effects of Aspergillus candidus metabolites against hydrogen peroxide-induced oxidative damage to Int 407 cells. Food Chem. Toxicol. 2003, 41:1561-1567.
12. He L., Li X., Luo H.S., Rong H., Cai J. Possible mechanism for the regulation of glucose on proliferation, inhibition and apoptosis of colon cancer cells induced by sodium butyrate. World J. Gastroenterol. 2007, 13:4015-4018.
13. Lankaputhra W.E.V., Shah N.P. Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res. 1998, 397:169-182.
14. Sreekumar O., Hosono A. The antimutagenic properties of a polysaccharide produced by Bifidobacterium longum and its cultured milk against some heterocyclic amines. Can. J. Microbiol. 1998, 44:1029-1036.
15. van Geel-Schutten G.H., Flesch F., ten Brink B., Smith M.R., Dijkhuizen L. Screening and characterization of Lactobacillus strains producing large mounts of exopolysaccharides. Appl. Microbiol. Biotechnol. 1998, 50:697-703.
16. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
17. Zhang L., Li N., Caicedo R., Neu J. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-α-induced interleukin-8 production in Caco-2 cells. J. Nutr. 2005, 135:1752-1756.
18. Zabala A., Martín M.R., Haza A.I., Fernández L., Rodríguez J.M., Morales P. Anti-proliferative effect of two lactic acid bacteria strains of human origin on the growth of a myeloma cell line. Lett. Appl. Microbiol. 2001, 32:287-292.
19. Kim J.Y., Woo H.J., Kim Y.S., Lee H.J. Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines. Biotechnol. Lett. 2002, 24:1431-1436.
20. Liebler-Tenorio E.M., Pohlenz J.F. Experimental mucosal disease of cattle: changes in cell proliferation in lymphoid tissues and intestinal epithelium. J. Comp. Pathol. 1997, 117:339-350.
21. Otte J.M., Chen C., Brunke G., Kiehne K., Schmitz F., Fölsch U.R., Herzig K.H. Mechanisms of lectin (phytohemagglutinin)-induced growth in small intestinal epithelial cells. Digestion 2001, 64:169-178.
22. Comalada M., Bailón E., de Haro O., Lara-Villoslada F., Xaus J., Zarzuelo A., Gálvez J. The effects of short-chain fatty acids on colon epithelial cell proliferation and survival depend on the cellular phenotype. J. Cancer Res. Clin. Oncol. 2006, 132:487-497.
23. Weerasooriya V., Rennie M.J., Anant S., Alpers D.H., Patterson B.W., Klein S. Dietary fiber decreases colonic epithelial cell proliferation and protein synthetic rates in human subjects. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E1104-1108.
24. Oda M., Haegawa H., Komatsu S., Kambe M., Tsuchiya F. Antitumor polysaccharide from Lactobacillus sp. Agric. Biol. Chem. 1983, 47:1623-1625.
25. Speit G., Hartmann A. The contribution of excision repair to the DNA effects seen in the alkaline single cell gel test (comet assay). Mutagenesis 1995, 10:555-559.